Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of this bioequivalence study is to compare the test of Rivastigmine 1.5 mg Capsules of Dr.Reddy\'s Laboratories Limited with reference to Exelon 1.5 mg of Novartis in Healthy Subjects Under Fed Conditions.
Epistemonikos ID: c159bf69a8bdbc685782bd95b864000f2d1bb110
First added on: May 05, 2024